See What HealthDay Can Do For You
Contact Us

Excess Risk for Diabetes-Linked Heart Failure Greater in Women

Women with type 1, type 2 diabetes have greater excess risk for heart failure versus men

stethoscope

FRIDAY, July 19, 2019 (HealthDay News) -- The excess risk for heart failure associated with diabetes is significantly greater in women than men, according to a meta-analysis published online July 18 in Diabetologia.

Toshiaki Ohkuma, Ph.D., from the University of New South Wales in Sydney, and colleagues conducted a systematic review and meta-analysis to examine possible sex differences in the excess risk for heart failure consequent to diabetes. Studies that reported sex-specific estimates of relative risks (RRs) for heart failure associated with diabetes were included. Pooled sex-specific RRs were obtained, and the authors assessed the women-to-men ratio of RRs (RRRs) for heart failure associated with diabetes.

Data were included for 47 cohorts with 12,142,998 individuals and 253,260 heart failure events. The researchers found that the pooled multiple-adjusted RR for heart failure associated with type 1 diabetes was 5.15 and 3.47 in women and men, respectively, yielding a RRR of 1.47. For heart failure associated with type 2 diabetes, the corresponding RRs were 1.95 and 1.74 in women and men, respectively, yielding a pooled RRR of 1.09.

"The excess risk of heart failure following diagnosis of diabetes is significantly greater in women than men, highlighting the importance of intensive prevention and treatment of diabetes for women as well as men," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.